Potential role of vitamin D in patients with diabetes,dyslipidaemia,and COVID-19  

作　　者：Ming-Ke Wang Xue-Lu Yu Li-Yun Zhou Hong-Mei Si Ju-Fen Hui Ji-Shun Yang 

机构地区：[1]Department of Disease Control and Prevention,Naval Medical Center of PLA,Naval Medical University,Shanghai 200052,China [2]Medical Care Center,Naval Medical Center of PLA,Naval Medical University,Shanghai 200052,China

出　　处：《World Journal of Critical Care Medicine》2022年第2期112-114,共3页世界重症医学杂志

摘　　要：Coronavirus disease 2019(COVID-19)caused by severe acute respiratory syndrome coronavirus-2 has become a worldwide public health crisis.Studies have demonstrated that diabetes and dyslipidaemia are common comorbidities and could be high-risk factors for severe COVID-19.Vitamin D,a group of fatsoluble compounds responsible for intestinal absorption of calcium,magnesium,and phosphate,has been widely used as a dietary supplement for the prevention and treatment of numerous diseases,including infectious and non-infectious diseases,due to its high cost-effectiveness;safety;tolerability;and anti-thrombotic,anti-inflammatory,antiviral,and immunomodulatory properties.In this letter to the editor,we mainly discuss the potential role of vitamin D in patients with diabetes,dyslipidaemia,and COVID-19.

关 键 词：Coronavirus disease 2019 Severe acute respiratory syndrome coronavirus-2 Vitamin D DIABETES DYSLIPIDAEMIA 

分 类 号：R563.1[医药卫生—呼吸系统] R587.1[医药卫生—内科学] R589.2[医药卫生—临床医学]